Doxorubicin and two of its analogues are preferential inducers of homologous recombination compared with mutational events in somatic cells of Drosophila melanogaster-Reference-Cited by-同舟云学术

Doxorubicin and two of its analogues are preferential inducers of homologous recombination compared with mutational events in somatic cells of Drosophila melanogaster

Published:2003-08 Issue:1-2 Volume:539 Page:167-175
ISSN:1383-5718
Container-title:Mutation Research/Genetic Toxicology and Environmental Mutagenesis
language:en
Short-container-title:Mutation Research/Genetic Toxicology and Environmental Mutagenesis

Author:

Lehmann Mauricio,Franco Aline,de Souza Prudente Vilar Knulp,Luı́za Reguly Maria,de Andrade Heloı́sa Helena Rodrigues

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics

Reference47 articles.

1. New developments in antitumour anthracyclines;Arcamone;Pharmacol. Ther.,1997

2. Clinical applications of anticancer drugs targeted to topoisomerase II;Hande;Biochim. Biophys. Acta,1998

3. Recent developments in the field of antitumour anthracyclines;Monneret;Eur. J. Med. Chem.,2001

4. From the pigments of the actinomycetes to third generation antitumour anthracyclines;Arcamone;Biochemie,1998

5. Mutagenic properties of topoisomerase-targeted drugs;Baguley;Biochim. Biophys. Acta,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Drosophila model relevant to chemotherapy-related cognitive impairment;Scientific Reports;2023-11-07

2. ADrosophilamodel of chemotherapy-related cognitive impairment;2023-06-05

3. Fruit fly for anticancer drug discovery and repurposing;Annals of Medicine & Surgery;2023-02

4. Modulating effect of DL-kavain on the mutagenicity and carcinogenicity induced by doxorubicin in Drosophila melanogaster;Journal of Toxicology and Environmental Health, Part A;2021-06-27

5. Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells;BMC Veterinary Research;2020-09-24